Citadel Advisors’s Asensus Surgical, Inc. ASXC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-400
| Closed | -$92 | – | 15711 |
|
|
2024
Q1 | $92 | Sell |
400
-32,900
| -99% | -$9.56K | ﹤0.01% | 14432 |
|
|
2023
Q4 | $10.6K | Sell |
33,300
-200
| -0.6% | -$52 | ﹤0.01% | 13097 |
|
|
2023
Q3 | $9.04K | Buy |
33,500
+7,100
| +27% | +$2.58K | ﹤0.01% | 13149 |
|
|
2023
Q2 | $13.3K | Buy |
26,400
+12,900
| +96% | +$7.71K | ﹤0.01% | 13045 |
|
|
2023
Q1 | $8.88K | Sell |
13,500
-25,800
| -66% | -$17.5K | ﹤0.01% | 13627 |
|
|
2022
Q4 | $13.6K | Sell |
39,300
-19,100
| -33% | -$7.76K | ﹤0.01% | 13433 |
|
|
2022
Q3 | $26K | Sell |
58,400
-3,400
| -6% | -$1.77K | ﹤0.01% | 11975 |
|
|
2022
Q2 | $25K | Buy |
61,800
+4,700
| +8% | +$2.1K | ﹤0.01% | 12315 |
|
|
2022
Q1 | $36K | Buy |
57,100
+16,000
| +39% | +$12.3K | ﹤0.01% | 13008 |
|
|
2021
Q4 | $46K | Sell |
41,100
-89,500
| -69% | -$138K | ﹤0.01% | 13297 |
|
|
2021
Q3 | $242K | Sell |
130,600
-3,300
| -2% | -$7.41K | ﹤0.01% | 11552 |
|
|
2021
Q2 | $424K | Sell |
133,900
-39,100
| -23% | -$97.7K | ﹤0.01% | 10428 |
|
|
2021
Q1 | $562K | Buy |
173,000
+141,500
| +449% | +$512K | ﹤0.01% | 9424 |
|
|
2020
Q4 | $20K | Buy |
+31,500
| New | +$14.4K | ﹤0.01% | 10782 |
|
|
2019
Q4 | – | Sell |
-7,400
| Closed | -$60K | – | 9910 |
|
|
2019
Q3 | $60K | Buy |
7,400
+2,346
| +46% | +$31.9K | ﹤0.01% | 8656 |
|
|
2019
Q2 | $89K | Sell |
5,054
-11,800
| -70% | -$258K | ﹤0.01% | 8574 |
|
|
2019
Q1 | $521K | Sell |
16,854
-5,738
| -25% | -$192K | ﹤0.01% | 6722 |
|
|
2018
Q4 | $664K | Sell |
22,592
-4,777
| -17% | -$217K | ﹤0.01% | 5959 |
|
|
2018
Q3 | $2.06M | Buy |
27,369
+13,900
| +103% | +$941K | ﹤0.01% | 4364 |
|
|
2018
Q2 | $763K | Buy |
13,469
+9,661
| +254% | +$352K | ﹤0.01% | 5677 |
|
|
2018
Q1 | $84K | Sell |
3,808
-5,238
| -58% | -$120K | ﹤0.01% | 7777 |
|
|
2017
Q4 | $227K | Buy |
9,046
+7,938
| +716% | +$244K | ﹤0.01% | 6918 |
|
|
2017
Q3 | $21K | Sell |
1,108
-946
| -46% | -$11K | ﹤0.01% | 7352 |
|
|
2017
Q2 | $19K | Sell |
2,054
-100
| -5% | -$951 | ﹤0.01% | 7303 |
|
|
2017
Q1 | $34K | Buy |
2,154
+723
| +51% | +$12.5K | ﹤0.01% | 7142 |
|
|
2016
Q4 | $24K | Buy |
1,431
+646
| +82% | +$13.2K | ﹤0.01% | 7044 |
|
|
2016
Q3 | $17K | Sell |
785
-1,561
| -67% | -$28.5K | ﹤0.01% | 7095 |
|
|
2016
Q2 | $37K | Buy |
2,346
+1,269
| +118% | +$39.8K | ﹤0.01% | 6471 |
|
|
2016
Q1 | $60K | Buy |
+1,077
| New | +$46.1K | ﹤0.01% | 6205 |
|
|
2015
Q4 | – | Sell |
-77
| Closed | -$2K | – | 9311 |
|
|
2015
Q3 | $2K | Buy |
+77
| New | +$2.85K | ﹤0.01% | 8748 |
|
Other funds holding ASXC
BCM
MCM
CM
Citadel Advisors's ASXC Position: Q2 2024 in Review
Citadel Advisors sold out of Asensus Surgical, Inc. (ASXC) in Q2 2024, closing a stake of 26,106 shares — an estimated $6K sold.
Citadel Advisors first reported a position in ASXC in Q2 2015 and held it in 21 quarters. The position peaked at $8.15M in Q1 2021. 64 funds tracked by Wall St. Rank hold ASXC as of Q2 2024.
- Citadel Advisors reported no remaining Asensus Surgical, Inc. position as of Q2 2024 after selling out during the quarter.
- Citadel Advisors sold 26,106 Asensus Surgical, Inc. shares in Q2 2024, an estimated $6K.
- Citadel Advisors first reported a position in Asensus Surgical, Inc. in Q2 2015 and held it in 21 quarters.
- Citadel Advisors's Asensus Surgical, Inc. position peaked at $8.15M in Q1 2021.
- 64 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2024.
Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.